Vanda Pharmaceuticals Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $216.1 | $198.8 | $192.6 | $254.4 | $268.7 |
| Operating income | -$151.2 | -$40.7 | -$14.0 | $6.3 | $42.2 |
| Net income | -$220.5 | -$18.9 | $2.5 | $6.3 | $33.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$110.4 | -$16.2 | $12.4 | $31.3 | $63.7 |
Shares outstanding 60.1M · Free float 80.1%
Annual filing data through FY ended December 31, 2025; float as of August 25, 2026.